Entera Bio Ltd. ENTX 深 沪
已收盘 12-19 16:00:00 美东时间
1.77
-0.170
-8.76%
华盛通- 最 高2.7299
- 今 开1.95
- 成交量 26.94万股
- 最 低 1.75
- 昨 收 1.94
- 总市值 5099.35万
- 52周最高 3.22
- 市盈率 静 --
- 换手率 0.94%
- 52周最低 1.5006
- 委 比 -38.26%
- 总股本 2880.99万
- 历史最高 10.16
- 量 比 4.47
- 振 幅 50.51%
- 历史最低 0.47
- 每 手 1
- 风险率 0.30%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Entrada Therapeutics Receives Authorization in the European Union to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in Patients Living with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping
Entrada Therapeutics secures EU authorization for ELEVATE-45-201, a Phase 1/2 study of ENTR-601-45 for Duchenne muscular dystrophy patients amenable to exon 45 skipping. The study aims to assess safety, tolerability, and efficacy, with initiation planned for Q3 2025. ENTR-601-45 is an exon-skipping therapy designed to restore dystrophin production, addressing a significant unmet need in this DMD subpopulation.
05-28 11:00
